Insider Stock Trading History of Maraganore John

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Maraganore John since year 2005. The trader's CIK number is 1180432. At the time of this reporting, Maraganore John is the Chief Executive Officer of Alnylam Pharmaceuticals, Inc. . (stock ticker symbol ALKS). See this page for all insider trading activities at Alnylam Pharmaceuticals, Inc. .

Note that in the past MARAGANORE JOHN also reported insider trading activities as an insider of the following companies:

Stock purchases, sales, and option exercises reported by insider Maraganore John since 2005.

Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2017-12-19	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	1,587	63.00	99,981
2017-11-22	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	73,415	31.39	2,304,496
2017-11-22	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	73,415	131.35	9,643,060
2017-11-15	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	74,000	31.39	2,322,860
2017-11-15	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	74,000	127.99	9,471,482
2017-09-14	BLUE	Bluebird Bio, Inc.	Option Ex	18,868	2.09	39,434
2017-09-14	BLUE	Bluebird Bio, Inc.	Sale	18,868	131.50	2,481,236
2017-08-02	BLUE	Bluebird Bio, Inc.	Sale	2,754	96.74	266,424
2017-08-24	BLUE	Bluebird Bio, Inc.	Option Ex	13,839	2.09	28,923
2017-08-24	BLUE	Bluebird Bio, Inc.	Sale	11,085	95.72	1,061,100
2017-03-03	BLUE	Bluebird Bio, Inc.	Option Ex	13,839	3.22	44,616
2017-03-03	BLUE	Bluebird Bio, Inc.	Sale	13,839	85.02	1,176,647
2017-01-05	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	1,340	18.66	25,004
2016-12-12	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	30,151	22.75	685,935
2016-10-12	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	7,540	12.88	97,115
2016-07-19	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	15,076	22.75	342,979
2016-07-20	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	15,075	22.75	342,956
2016-07-19	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	15,076	64.14	967,004
2016-07-20	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	15,075	65.28	984,141
2016-04-20	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	15,075	67.81	1,022,235
2016-04-19	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	15,076	67.91	1,023,796
2016-04-20	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	15,075	22.75	342,956
2016-04-19	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	15,076	22.75	342,979
2016-01-20	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	15,076	70.50	1,062,903
2016-01-19	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	15,076	74.49	1,122,966
2016-01-20	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	15,076	22.75	342,979
2016-01-19	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	15,076	22.75	342,979
2015-12-02	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	58,689	13.12	769,999
2015-12-02	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	58,689	104.99	6,161,523
2015-11-20	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	69,254	10.11	700,157
2015-11-20	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	58,690	103.14	6,053,580
2015-01-26	ALNY	Alnylam Pharmaceuticals, Inc.	Buy	10,000	95.00	950,000
2014-12-19	BLUE	Bluebird Bio, Inc.	Buy	2,352	85.00	199,920
2014-12-16	AGIO	Agios Pharmaceuticals Inc	Buy	1,806	110.75	200,014
2014-12-15	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	8,205	9.14	74,993
2014-09-18	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	56,834	78.67	4,471,301
2014-09-17	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	56,834	76.55	4,350,529
2014-09-17	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	56,834	7.47	424,549
2014-09-18	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	56,834	7.47	424,549
2014-07-14	BLUE	Bluebird Bio, Inc.	Buy	2,941	34.00	99,994
2014-06-26	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	56,834	65.59	3,727,628
2014-06-25	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	56,834	66.08	3,755,306
2014-06-26	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	56,834	7.47	424,549
2014-06-25	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	56,834	7.47	424,549
2014-06-23	AGIO	Agios Pharmaceuticals Inc	Buy	2,300	43.98	101,154
2014-05-14	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	56,834	57.42	3,263,635
2014-05-15	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	56,834	56.39	3,204,755
2014-05-14	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	56,834	6.78	385,334
2014-05-15	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	56,834	7.12	404,942
2014-04-29	AGIO	Agios Pharmaceuticals Inc	Buy	2,250	44.00	99,000
2014-04-14	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	28,707	19.03	546,294
2013-07-24	AGIO	Agios Pharmaceuticals Inc	Buy	8,333	18.00	149,994
2014-02-03	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	46,331	6.78	314,124
2013-10-10	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	12,665	6.78	85,868
2013-09-11	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	58,947	56.26	3,316,122
2013-09-11	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	58,947	.95	55,999
2013-08-14	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	60,000	48.92	2,935,140
2013-08-14	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	60,000	.95	57,000
2013-07-10	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	60,000	37.11	2,226,840
2013-07-10	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	60,000	.95	57,000
2013-02-27	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	30,000	23.47	704,010
2013-02-28	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	28,503	23.50	669,906
2012-12-19	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	18,617	.47	8,843
2012-02-21	ALNY	Alnylam Pharmaceuticals, Inc.	Buy	5,581	10.75	59,995
2012-01-09	ALNY	Alnylam Pharmaceuticals, Inc.	Buy	1,134	8.81	9,995
2011-12-12	ALNY	Alnylam Pharmaceuticals, Inc.	Buy	1,397	7.16	9,995
2011-11-14	ALNY	Alnylam Pharmaceuticals, Inc.	Buy	1,411	7.08	9,996
2011-10-11	ALNY	Alnylam Pharmaceuticals, Inc.	Buy	1,480	6.75	9,988
2010-08-17	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	50,000	.47	23,750
2009-06-16	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	40,000	21.80	871,800
2009-06-18	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	40,000	21.37	854,640
2009-06-17	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	40,000	21.40	855,840
2009-06-18	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	40,000	.47	19,000
2009-06-16	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	40,000	.47	19,000
2009-06-17	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	40,000	.47	19,000
2008-08-18	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	750	.47	356
2008-08-14	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	37,500	34.23	1,283,512
2008-08-13	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	37,500	33.95	1,272,975
2008-08-14	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	37,500	.47	17,812
2008-08-13	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	37,500	.47	17,812
2008-06-30	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	3,000	.47	1,425
2007-06-28	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	37,500	.47	17,812
2007-06-29	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	18,722	15.40	288,243
2007-06-29	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	37,500	.47	17,812
2007-06-28	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	17,431	16.11	280,778
2007-06-28	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	20,069	15.92	319,498
2007-06-29	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	1,689	16.20	27,366
2007-06-29	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	17,089	15.83	270,553
2006-05-12	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	28,313	15.20	430,300
2006-05-12	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	37,500	.47	17,812
2006-05-16	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	1,000	15.05	15,050
2006-05-15	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	41,635	15.07	627,647
2006-05-12	ALNY	Alnylam Pharmaceuticals, Inc.	Sale	13,322	15.72	209,395
2006-05-15	ALNY	Alnylam Pharmaceuticals, Inc.	Option Ex	37,500	.47	17,812

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Maraganore John (Chief Executive Officer of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.